Literature DB >> 11145613

Angiotensin II as a trophic factor of white adipose tissue: stimulation of adipose cell formation.

P Saint-Marc1, L P Kozak, G Ailhaud, C Darimont, R Negrel.   

Abstract

White adipose tissue is known to contain the components of the renin-angiotensin system giving rise to angiotensin II (AngII). In vitro, prostacyclin is synthesized from arachidonic acid through the activity of cyclooxygenases 1 and 2 and is released from AngII-stimulated adipocytes. Prostacyclin, in turn, is able to favor adipocyte formation. Based upon in vivo and ex vivo experiments combined to immunocytochemical staining of glycerol-3-phosphate dehydrogenase (GPDH), an indicator of adipocyte formation, it is reported herein that AngII favors the appearance of GPDH-positive cells. In the presence of a cyclooxygenase inhibitor, this adipogenic effect is abolished, whereas that of (carba)prostacyclin, a stable analog of prostacyclin that bypasses this inhibition, appears unaltered. Taken together, these results are in favor of AngII acting as a trophic factor implicated locally in adipose tissue development. It is proposed that AngII enhances the formation of GPDH-expressing cells from preadipocytes in response to prostacyclin released from adipocytes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11145613     DOI: 10.1210/endo.142.1.7883

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  25 in total

1.  Adipocyte-specific deficiency of angiotensinogen decreases plasma angiotensinogen concentration and systolic blood pressure in mice.

Authors:  Frederique Yiannikouris; Michael Karounos; Richard Charnigo; Victoria L English; Debra L Rateri; Alan Daugherty; Lisa A Cassis
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-11-09       Impact factor: 3.619

2.  Adipogenic differentiation of adipose tissue-derived human mesenchymal stem cells: effect of gastric bypass surgery.

Authors:  Jie-Gen Chen; Anna Spagnoli; Alfonso Torquati
Journal:  Surg Endosc       Date:  2012-05-31       Impact factor: 4.584

3.  Regulated renin release from 3T3-L1 adipocytes.

Authors:  Jason D Fowler; Nathan D Johnson; Thomas A Haroldson; Joy A Brintnall; Julio E Herrera; Stephen A Katz; David A Bernlohr
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-03-17       Impact factor: 4.310

4.  Human adipose angiotensinogen gene expression and secretion are stimulated by cyclic AMP via increased DNA cyclic AMP responsive element binding activity.

Authors:  Valérie Serazin; Esther Dos Santos; Mireille Morot; Yves Giudicelli
Journal:  Endocrine       Date:  2004-11       Impact factor: 3.633

Review 5.  The renin angiotensin system and the metabolic syndrome.

Authors:  Annette D de Kloet; Eric G Krause; Stephen C Woods
Journal:  Physiol Behav       Date:  2010-04-08

6.  Long-term angiotensin II AT1 receptor inhibition produces adipose tissue hypotrophy accompanied by increased expression of adiponectin and PPARgamma.

Authors:  Stefan Zorad; Jing-tao Dou; Julius Benicky; Daniel Hutanu; Katarina Tybitanclova; Jin Zhou; Juan M Saavedra
Journal:  Eur J Pharmacol       Date:  2006-09-09       Impact factor: 4.432

Review 7.  The intricacies of the renin-angiotensin-system in metabolic regulation.

Authors:  Erin B Bruce; Annette D de Kloet
Journal:  Physiol Behav       Date:  2016-11-22

Review 8.  Role of ACE inhibitors in treating hypertensive diabetic patients.

Authors:  Dmitri Kirpichnikov; James R Sowers
Journal:  Curr Diab Rep       Date:  2002-06       Impact factor: 4.810

9.  Renin dynamics in adipose tissue: adipose tissue control of local renin concentrations.

Authors:  Jason D Fowler; Stacy B Krueth; David A Bernlohr; Stephen A Katz
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-12-02       Impact factor: 4.310

10.  Aliskiren reduces body-weight gain, adiposity and plasma leptin during diet-induced obesity.

Authors:  Paula Stucchi; Victoria Cano; Mariano Ruiz-Gayo; María S Fernández-Alfonso
Journal:  Br J Pharmacol       Date:  2009-08-19       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.